These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Statins and myotoxicity. Yan L; Lan F; Wang ZG; Li YP Trends Pharmacol Sci; 2003 Mar; 24(3):113-4. PubMed ID: 12628352 [No Abstract] [Full Text] [Related]
5. Localized rhabdomyolysis after exertion in a cardiac transplant recipient on statin therapy. Biggs MJ; Bonser RS; Cram R J Heart Lung Transplant; 2006 Mar; 25(3):356-7. PubMed ID: 16507432 [TBL] [Abstract][Full Text] [Related]
6. [Myopathy with rhabdomyolysis as an adverse effect of simultaneous treatment with cerivastatin and gemfibrozil]. Huić M; Anić B; Cikes N; Bosnić D; Sentić M; Markeljević J; Mayer M; Pazanin L Lijec Vjesn; 2002; 124(3-4):73-6. PubMed ID: 18956824 [TBL] [Abstract][Full Text] [Related]
7. Rhabdomyolysis and cerivastatin: was it a problem of dose? Kalaria D; Wassenaar W CMAJ; 2002 Oct; 167(7):737. PubMed ID: 12389822 [No Abstract] [Full Text] [Related]
8. On call. Statins and muscle damage. Simon HB Harv Mens Health Watch; 2007 Aug; 12(1):8. PubMed ID: 18018322 [No Abstract] [Full Text] [Related]
9. Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis. McAdams M; Staffa J; Dal Pan G Pharmacoepidemiol Drug Saf; 2008 Mar; 17(3):229-39. PubMed ID: 18175291 [TBL] [Abstract][Full Text] [Related]
10. [Cerivastatin and acute kidney failure caused by rhabdomyolysis]. Bravo JJ; Novoa D; Romero R; Sánchez-Guisande D Nefrologia; 2001; 21(5):509. PubMed ID: 11795023 [No Abstract] [Full Text] [Related]
11. Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin. Schindler C; Thorns M; Matschke K; Tugtekin SM; Kirch W Clin Ther; 2007 Jan; 29(1):172-6. PubMed ID: 17379057 [TBL] [Abstract][Full Text] [Related]
12. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction. Kind AH; Zakowski LJ; McBride PE WMJ; 2002; 101(7):53-6. PubMed ID: 12426921 [TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen. Marsà Carretero M; Alos Manrique C; Valles Callol JA Br J Gen Pract; 2002 Mar; 52(476):235-6. PubMed ID: 12030671 [No Abstract] [Full Text] [Related]
15. Cerivastatin-induced rhabdomyolisis in a patient with diabetic nephropathy. Marigliano N; Castellano I; Sánchez O; Covarsí A Am J Nephrol; 2001; 21(1):86. PubMed ID: 11275641 [No Abstract] [Full Text] [Related]
16. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors. Jamal SM; Eisenberg MJ; Christopoulos S Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341 [TBL] [Abstract][Full Text] [Related]
17. [Rhabdomyolysis, acute renal failure and use of cerivastatin combined with gemfibrozil. New evidence]. SantaCruz PL; González A; León ME; Fernández MY Nefrologia; 2002; 22(3):301-2. PubMed ID: 12123135 [No Abstract] [Full Text] [Related]
18. The withdrawal of Baycol (cerivastatin). Griffin JP Adverse Drug React Toxicol Rev; 2001 Dec; 20(4):177-80. PubMed ID: 11770168 [No Abstract] [Full Text] [Related]
19. The cerivastatin withdrawal crisis: a "post-mortem" analysis. Maggini M; Raschetti R; Traversa G; Bianchi C; Caffari B; Da Cas R; Panei P Health Policy; 2004 Aug; 69(2):151-7. PubMed ID: 15212862 [TBL] [Abstract][Full Text] [Related]
20. [Rhabdomyolisis associated with cerivastatin and cyclosporine combination therapy]. Nicolás De Prado I; Miras López M; Morán Sánchez S; Mercader Martínez J Med Clin (Barc); 2002 May; 118(18):716-7. PubMed ID: 12042140 [No Abstract] [Full Text] [Related] [Next] [New Search]